Nelson Steven H 4
4 · Health Catalyst, Inc. · Filed Jul 20, 2026
Research Summary
AI-generated summary of this filing
Health Catalyst (HCAT) Director Steven H. Nelson Receives RSU Award
What Happened
- Steven H. Nelson, a director of Health Catalyst, was granted 80,691 restricted stock units (RSUs) on 2026-07-16. The Form 4 reports the acquisition price as $0.00 because these RSUs are a compensatory award, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-07-16; Form 4 filed: 2026-07-20 (timely per two-business-day rule).
- Amount granted: 80,691 RSUs; reported acquisition price: $0.00.
- Shares owned after transaction: not specified in the provided filing excerpt.
- Transaction code: A (award/grant).
- Footnote: RSUs granted under the Issuer’s 2019 Stock Option and Incentive Plan. Each RSU represents a contingent right to one share. Vesting occurs on the earlier of (i) one year after grant or (ii) the date of the next Annual Meeting of stockholders.
Context
- RSUs are a form of equity compensation; they convert to actual shares only upon vesting and typically trigger tax withholding when settled. This award reflects compensation to a director and is not the same as a purchase (which some investors view as a stronger bullish signal).
Insider Transaction Report
Form 4
Nelson Steven H
Director
Transactions
- Award
Common Stock
[F1]2026-07-16+80,691→ 235,499 total
Footnotes (1)
- [F1]Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, the RSUs will fully vest on the earlier of (i) the one-year anniversary of the grant date or (ii) the date of the next Annual Meeting of the Issuer's Stockholders.
Signature
/s/ Benjamin Landry, as Attorney-in-Fact|2026-07-20